Patent · US Active

Compositions, systems, and methods for genome editing

US11479762B1 · kind B1 · utility

0Cited by
15References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2019
Grant dateOct 25, 2022
Priority date
Expiry dateAug 7, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This disclosure provides compositions, recombinant expression constructs, and engineered systems that include a polynucleotide including or encoding a Cas12a tracrRNA, and methods for their use. The materials and methods of the disclosure are especially suited to sequence-specific genome editing of eukaryotic genomic sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.